Healthcare & Life Sciences
Ignis Therapeutics
Ignis Therapeutics is a Healthcare & Life Sciences startup based in China, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
2020
Founded
1
Investors
About Ignis Therapeutics
Based in China, Ignis Therapeutics is a startup founded in 2020. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ignis Therapeutics is a biotechnology company founded in late 2020 that focuses on developing innovative treatments for major brain diseases including epilepsy, excessive daytime sleepiness, insomnia, Parkinson's disease, schizophrenia, and depression, with a current pipeline of 20 products.
Explore Ignis Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.